TRPV4 and macular retinal edema: Furthermore, GlaxoSmithKline have reported several clinical trials utilizing TRPV4 antagonists for the treatment of various edema indications, including pulmonary edema, chronic cough, congestive heart failure, and macular edema [[94], NCT02497937, NCT02119260].